RT Journal Article
SR Electronic
T1 Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56<sup>bright</sup>CD16<sup>−</sup> subset
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003385corr1
DO 10.1136/jitc-2021-003385corr1
VO 10
IS 3
YR 2022
UL http://jitc.bmj.com/content/10/3/e003385corr1.abstract